Ralph Karler

3.5k total citations
83 papers, 3.0k citations indexed

About

Ralph Karler is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Ralph Karler has authored 83 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cellular and Molecular Neuroscience, 37 papers in Pharmacology and 34 papers in Molecular Biology. Recurrent topics in Ralph Karler's work include Neuroscience and Neuropharmacology Research (53 papers), Cannabis and Cannabinoid Research (37 papers) and Neurotransmitter Receptor Influence on Behavior (27 papers). Ralph Karler is often cited by papers focused on Neuroscience and Neuropharmacology Research (53 papers), Cannabis and Cannabinoid Research (37 papers) and Neurotransmitter Receptor Influence on Behavior (27 papers). Ralph Karler collaborates with scholars based in United States. Ralph Karler's co-authors include Stuart A. Turkanis, Larry D. Calder, Imtiaz A. Chaudhry, J.Brent Bedingfield, D. M. Woodbury, Donna M. Olsen, Kevin T. Finnegan, Lester M. Partlow, Pauline Chiu and Hall Downes and has published in prestigious journals such as Science, Analytical Biochemistry and Brain Research.

In The Last Decade

Ralph Karler

83 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Karler United States 30 2.2k 1.1k 991 433 331 83 3.0k
Michel Héaulme France 20 2.4k 1.1× 1.3k 1.1× 1.7k 1.7× 431 1.0× 120 0.4× 34 3.5k
François Petitet France 21 2.5k 1.1× 1.1k 1.0× 1.4k 1.4× 683 1.6× 148 0.4× 45 3.5k
Albert Weissman United States 18 1.6k 0.7× 791 0.7× 405 0.4× 363 0.8× 206 0.6× 53 2.8k
F.M. Leslie United States 31 2.2k 1.0× 1.6k 1.4× 1.2k 1.2× 537 1.2× 133 0.4× 45 3.6k
Edmund Przegaliński Poland 36 3.0k 1.3× 1.7k 1.5× 839 0.8× 421 1.0× 423 1.3× 188 4.5k
Zofia Rogóż Poland 31 1.9k 0.8× 1000 0.9× 751 0.8× 275 0.6× 367 1.1× 162 3.1k
H. Ladinsky Italy 34 2.3k 1.0× 2.0k 1.7× 534 0.5× 450 1.0× 181 0.5× 106 3.4k
Edward D. French United States 38 3.5k 1.6× 1.8k 1.6× 722 0.7× 759 1.8× 429 1.3× 73 4.6k
Douglas W. Bonhaus United States 31 2.2k 1.0× 1.6k 1.4× 477 0.5× 333 0.8× 320 1.0× 78 3.6k
Robert J. Naylor United Kingdom 39 2.9k 1.3× 2.0k 1.7× 518 0.5× 488 1.1× 466 1.4× 134 4.9k

Countries citing papers authored by Ralph Karler

Since Specialization
Citations

This map shows the geographic impact of Ralph Karler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Karler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Karler more than expected).

Fields of papers citing papers by Ralph Karler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Karler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Karler. The network helps show where Ralph Karler may publish in the future.

Co-authorship network of co-authors of Ralph Karler

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Karler. A scholar is included among the top collaborators of Ralph Karler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Karler. Ralph Karler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karler, Ralph, et al.. (1998). The Role of Dopamine in the Mouse Frontal Cortex. Pharmacology Biochemistry and Behavior. 61(4). 435–443. 28 indexed citations
2.
Karler, Ralph, et al.. (1995). The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Research. 671(1). 100–104. 62 indexed citations
3.
Karler, Ralph, et al.. (1994). A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Research. 658(1-2). 8–14. 75 indexed citations
4.
Karler, Ralph, Larry D. Calder, & J.Brent Bedingfield. (1994). Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115(3). 305–310. 106 indexed citations
5.
Karler, Ralph, Kevin T. Finnegan, & Larry D. Calder. (1993). Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Research. 603(1). 19–24. 67 indexed citations
6.
Karler, Ralph & Larry D. Calder. (1992). Excitatory amino acids and the actions of cocaine. Brain Research. 582(1). 143–146. 63 indexed citations
7.
Turkanis, Stuart A., Ralph Karler, & Lester M. Partlow. (1991). Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells. Brain Research. 560(1-2). 245–250. 12 indexed citations
8.
Turkanis, Stuart A., Lester M. Partlow, & Ralph Karler. (1991). Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells. Neuropharmacology. 30(1). 73–77. 22 indexed citations
9.
Partlow, Lester M., Ralph Karler, & Stuart A. Turkanis. (1990). Whole-cell voltage-clamp study of sodium current in neuroblastoma cells: effects of inhibition of neurite outgrowth by colchicine. Brain Research. 530(1). 102–104. 2 indexed citations
10.
Karler, Ralph, Larry D. Calder, & Stuart A. Turkanis. (1990). Reverse tolerance to amphetamine evokes reverse tolerance to 5-hydroxytryptophan. Life Sciences. 46(24). 1773–1780. 6 indexed citations
11.
Turkanis, Stuart A., Lester M. Partlow, & Ralph Karler. (1989). Effects of cocaine on neuromuscular transmission in the lobster. Neuropharmacology. 28(9). 971–975. 3 indexed citations
12.
Turkanis, Stuart A. & Ralph Karler. (1988). Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids. Neuropharmacology. 27(7). 737–742. 10 indexed citations
13.
Turkanis, Stuart A., Lester M. Partlow, & Ralph Karler. (1988). The effects of amphetamine on neuromuscular transmission in the lobster. Neuropharmacology. 27(12). 1221–1225. 2 indexed citations
14.
Chaudhry, Imtiaz A., Stuart A. Turkanis, & Ralph Karler. (1988). Characteristics of “reverse tolerance” to amphetamine-induced locomotor stimulation in mice. Neuropharmacology. 27(8). 777–781. 22 indexed citations
15.
Karler, Ralph & Stuart A. Turkanis. (1987). Different Cannabinoids Exhibit Different Pharmacological and Toxicological Properties. PsycEXTRA Dataset. 79. 96–107. 5 indexed citations
16.
Turkanis, Stuart A., et al.. (1982). Kindling‐like Effect Induced by Repeated Corneal Electro shock in Mice. Epilepsia. 23(5). 471–479. 36 indexed citations
17.
Turkanis, Stuart A., et al.. (1979). An Electrophysiological Analysis of the Anticonvulsant Action of Cannabidiol on Limbic Seizures in Conscious Rats. Epilepsia. 20(4). 351–363. 42 indexed citations
18.
Chiu, Pauline, et al.. (1979). The Influence of Cannabidiol and Δ9‐Tetrahydrocannabinol on Cobalt Epilepsy in Rats. Epilepsia. 20(4). 365–375. 56 indexed citations
19.
Karler, Ralph, et al.. (1979). DEVELOPMENT OF TOLERANCE TO THE PROLONGATION OF HEXOBARBITONE SLEEPING TIME CAUSED BY CANNABIDIOL. British Journal of Pharmacology. 67(1). 93–101. 20 indexed citations
20.
Karler, Ralph, et al.. (1974). A study of the relative anticonvulsant and toxic activities of delta9-tetrahydrocannabinol and its congeners.. PubMed. 7(2). 353–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Héaulme Breakdown of academic impact, for papers by François Petitet Breakdown of academic impact, for papers by Albert Weissman Breakdown of academic impact, for papers by F.M. Leslie Breakdown of academic impact, for papers by Edmund Przegaliński Breakdown of academic impact, for papers by Zofia Rogóż Breakdown of academic impact, for papers by H. Ladinsky Breakdown of academic impact, for papers by Edward D. French Breakdown of academic impact, for papers by Douglas W. Bonhaus Breakdown of academic impact, for papers by Robert J. Naylor
Rankless by CCL
2026